New AI start­up launch­es with $40M; Ob­sE­va an­nounces reg­u­la­to­ry holdup for flag­ship drug

4 years ago
News Briefing

With de­ci­sion loom­ing on J&J, Leg­end's CAR-T, an­a­lyst sees a new cham­pi­on emerg­ing in boom­ing BC­MA space

4 years ago
R&D

Break­ing with past com­ments, FDA's Richard Paz­dur telegraphs rough road ahead for Lil­ly's Chi­na-de­vel­oped can­cer drug

4 years ago
Pharma
FDA+

Months af­ter Tmu­ni­ty ground to a halt on clin­i­cal hold, cell ther­a­py pi­o­neer Oz Azam is jump­ing to a stealth start­up

4 years ago
People

Konek­sa lands new round of funds to de­vel­op app-based dig­i­tal bio­mark­er tech

4 years ago
Financing

‘We’re not that com­pa­ny’: John Hood is build­ing a biotech the old-fash­ioned way — and not just be­cause he has ...

4 years ago
Financing

Covid-19 roundup: Ox­ford vac­cine sci­en­tist says overblown safe­ty fears caused death of 'hun­dreds of thou­sand­s'; ...

4 years ago
Coronavirus

Er­ic Lan­der 'bul­lied and de­meaned' staff at White House sci­ence of­fice — in­ves­ti­ga­tion

4 years ago
People

Gen­mab, Seagen want cer­vi­cal can­cer to be seen in new 'Ce­Me' cam­paign along with pa­tient ad­vo­cates

4 years ago
Pharma
Marketing

FDA restarts do­mes­tic drug man­u­fac­tur­ing in­spec­tions

4 years ago
FDA+
Manufacturing

In up­hold­ing Mar­tin Shkre­li's life­time ban, judge rules any state­ment he makes about phar­ma could be a vi­o­la­tion

4 years ago
People
Pharma

How re­searchers can get a han­dle on the mon­key short­age for tox stud­ies: FDA ex­plains

4 years ago
R&D
FDA+

R&D heads play phar­ma mu­si­cal chairs; Shat­tered block­buster dreams; Death of Aduhelm?; and more

4 years ago
Weekly

Af­ter some lengthy de­lays, Sanofi gets the FDA's OK for a rare dis­ease drug

4 years ago
Pharma
FDA+

Sen­ate Fi­nance chair asks Rob Califf for more de­tails around po­ten­tial ac­cel­er­at­ed ap­proval re­forms

4 years ago
FDA+

Vas Narasimhan and Sev­erin Schwan each claimed pay pack­ets worth $12M+ for 2021

4 years ago
Pharma

BioN­Tech wait­ed to col­lect its $100M PRV un­til just be­fore Mod­er­na's Covid-19 vac­cine ap­proval

4 years ago
FDA+

Bris­tol My­er­s' Caforio: CELMoDs have po­ten­tial to re­place Revlim­id and Po­m­a­lyst as block­busters start to lose ...

4 years ago
R&D
Pharma

With thou­sands of jobs on the chop­ping block, 'noth­ing's off the table' at Sanofi. What's stay­ing and what's go­ing?

4 years ago
Pharma

Re­gen­eron looks to George Yan­copoulos' R&D arm — and part­ners — in hunt for its next big cash cows

4 years ago
R&D
Pharma

Pfiz­er lands on For­tune’s most ad­mired list, edg­ing out Dis­ney, Google and Star­bucks in an­nu­al rep­u­ta­tion rank­ing

4 years ago
R&D

Or­chard se­cures re­im­burse­ment for gene ther­a­py; UK fines drug­mak­ers $47M for an­ti­com­pet­i­tive scheme

4 years ago
News Briefing

Van­da's gas­tric drug flops in late-stage test, crash­ing the biotech's stock

4 years ago
R&D

Watch out, As­traZeneca: UCB un­corks late-stage suc­cess for $2.1B Soliris ri­val

4 years ago
R&D
First page Previous page 587588589590591592593 Next page Last page
A service from the Financial Times